Sector portfolio · VC firm · South Korea
Partners Investment's Biotech portfolio
Partners Investment has backed 11 Biotech startups in rounds we track, $562M between them, shown by the stage each has reached. The best-funded is Affamed Therapeutics.
Partners Investment's whole portfolioPartners Investment's profile
Funding by segment
- Series B$259M4
- Series C and later$219M3
- Series A$59M2
- Stage not reported$25M2
Where they are based
- United States5$329M
- South Korea5$63M
United States
South KoreaFounded
Total raised
- Under $1M0
- $1M to $10M4
- $10M to $50M2
- $50M to $250M5
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
11 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States5
- South Korea5
Startups by country, 2 countries in all.
Segment by segment
Series B
4 startups · $259M raised
AffaMed TherapeuticsAffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.-$170M
AltPepAltPep is a Seattle-based biotechnology company founded in 2018 that focuses on developing early disease-modifying treatments and United States$53M
Newracle GeneticsNewracle Genetics is a bio venture company that develops gene therapy products for neurological diseases.South Korea$27M- BTBionetix TherapeuticsBionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment.South Korea$9.3M
Series C and later
3 startups · $219M raised
Senda BiosciencesSenda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.United States$123M
Ring TherapeuticsRing Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2017 by Flagship Pioneering.United States$87M
Astrogen, inc.Astrogen, inc.South Korea$9.3M
Series A
2 startups · $59M raised
Adcentrx TherapeuticsAdcentrx Therapeutics is a clinical-stage biotechnology company based in San Diego, California, founded in 2021.United States$51M- LLyseNTechLyseNTech is a bacteriophage company that develops antibiotic-resistant bacteria.South Korea$8.2M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Partners Investment as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Partners Investment?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.